SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-19-000077
Filing Date
2019-05-09
Accepted
2019-05-09 16:04:23
Documents
61
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20190331.htm   iXBRL 10-Q 1264475
2 EX-31.1 lgnd33119exhibit311.htm EX-31.1 20927
3 EX-31.2 lgnd33119exhibit312.htm EX-31.2 21257
4 EX-32 lgnd33119exhibit321.htm EX-32.1 15609
10 LOGO lgnd-20190331_g1.jpg GRAPHIC 11735
  Complete submission text file 0000886163-19-000077.txt   6379366

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20190331.xsd EX-101.SCH 38874
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20190331_cal.xml EX-101.CAL 101269
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20190331_def.xml EX-101.DEF 219588
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20190331_lab.xml EX-101.LAB 557418
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20190331_pre.xml EX-101.PRE 360006
11 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20190331_htm.xml XML 1146528
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 19810438
SIC: 2834 Pharmaceutical Preparations